Clinical Trials Logo

Gastroesophageal Reflux Disease clinical trials

View clinical trials related to Gastroesophageal Reflux Disease.

Filter by:

NCT ID: NCT01753128 Completed - Clinical trials for Gastroesophageal Reflux Disease

Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn

Start date: December 2012
Phase: Phase 3
Study type: Interventional

Esophageal hypersensitivity/Functional heartburn are common among non-erosive reflux disease (NERD) patients who do not response to proton pump inhibitors. Whether tricyclic antidepressant improves NERD patient's symptoms remains unknown Aim of this randomized controlled trial study is to determine the efficacy of imipramine, which could increase esophageal pain thresholds in healthy volunteers, in comparison with placebo for treatment patients with esophageal hypersensitivity or functional heartburn evaluated by improvement of specific-symptom score and quality of life

NCT ID: NCT01742377 Completed - Clinical trials for Gastroesophageal Reflux Disease

Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic Patients

MCE
Start date: February 2010
Phase: N/A
Study type: Observational

The purpose of this study to assess efficacy of SE endoscopy in the detection of MCE in dyspeptic patients with or without GERD diagnosed by GerdQ or by endoscopy + PHM and in normal volunteers.

NCT ID: NCT01733810 Completed - Clinical trials for Gastroesophageal Reflux Disease

The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis

Start date: February 1, 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the role of hypoxia inducible factor (HIF)-2a on the production of inflammatory cytokines that lead to reflux esophagitis.

NCT ID: NCT01682265 Completed - Clinical trials for Gastroesophageal Reflux Disease

Stretta In Reflux Uncontrolled by IPP

SIRUP
Start date: March 26, 2012
Phase: N/A
Study type: Interventional

The aim of the study is to compare the Stretta procedure and the Sham procedure efficiency 6months post-procedure in reflux uncontrolled by intake of Inhibitors of Protons Pump (IPP) patients.

NCT ID: NCT01642615 Completed - Clinical trials for Gastroesophageal Reflux Disease

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents

Start date: July 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and effectiveness of treatment with once daily oral administration of dexlansoprazole delayed-release capsules in adolescents with erosive esophagitis (EE) and for maintenance of healed EE and relief of heartburn.

NCT ID: NCT01642602 Completed - Clinical trials for Gastroesophageal Reflux Disease

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents

Start date: July 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study was to assess the safety and effectiveness of once daily oral administration of dexlansoprazole delayed-release capsules in adolescent participants with symptomatic non-erosive gastroesophageal reflux disease (GERD).

NCT ID: NCT01601379 Completed - Clinical trials for Gastroesophageal Reflux Disease

Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.

PROFILE
Start date: June 2010
Phase: Phase 4
Study type: Observational

The purpose of this observational study (this means that no drug is being tested in this study) is to obtain updated and detailed information about the Gastroesophageal Reflux Disease (GERD) specificities in European patients. The information about patients suffering from typical GERD symptoms will be collected in order to establish a classification of adult patients profile based on the characteristics of GERD symptoms. This study will only involve data collection about the disease. The treatment will not be affected by the study.

NCT ID: NCT01578642 Completed - Clinical trials for Gastroesophageal Reflux Disease

Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease

Start date: September 2010
Phase: Phase 2
Study type: Interventional

The EndoStim Stimulation System is an investigational device intended to improve the lower esophageal sphincter (LES) resting tone and restore LES function in individuals suffering with gastroesophageal reflux disease (GERD).

NCT ID: NCT01576289 Completed - Clinical trials for Gastroesophageal Reflux Disease

Analysis of Biopsies From the Upper Gastrointestinal Tract

histoGERD
Start date: November 2011
Phase: N/A
Study type: Observational

Multicenter study to correlate histological findings in the upper gastrointestinal tract with endoscopic and clinical data.

NCT ID: NCT01536457 Completed - Asthma Clinical Trials

Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis Only

Start date: July 2011
Phase: N/A
Study type: Observational

There have been a number of studies which attribute causality between reflux disease and asthma. In addition, clinicians typically treat chronic asthmatics with high dose acid suppressing medications (e.g. lansoprazole). However, clinical trials only recently have shed some light on this dilemma, with recent studies suggesting that the association is not as clear. This "retrospective" analysis of a prospective study which treated mod-severe asthmatics with lansoprazole or placebo will enter the collected raw data into a database, then perform statistical analyses to determine if children with asthma treated with acid suppression improved their asthma compared to those receiving placebo.